Consumption and Rational use of Antimicrobials in South-East Asia Region, 2024

Overview

The monitoring of antimicrobial consumption (AMC) is an indispensable component of national efforts aimed at mitigating the growing threat of antimicrobial resistance (AMR).

Simultaneously, the monitoring of AMC is pivotal in supporting access to medicines by ensuring the availability and appropriate use of antimicrobial agents. Within the WHO South-East Asia Region, most countries are currently in the initial stages of establishing their national AMC surveillance monitoring systems.

This publication insights into the dynamic landscape of antimicrobial consumption within the region. It encompasses a comprehensive analysis of antimicrobial consumption data, categorized by therapeutic groups, adherence to national essential medicines lists, standard treatment guidelines, and the promotion of rational antimicrobial use.

The publication presents clear evidence and key messages to guide policymakers, health-care providers, and stakeholders of the South-East Asia Region in their decision-making processes. These are purposed to address the multifaceted challenges and opportunities inherent in antimicrobial consumption and aim to improve the rational use of medicines and the containment of antimicrobial resistance for better public health outcomes